Quarterly report [Sections 13 or 15(d)]

Business Combination - Intangible Assets Acquired (Details)

v3.26.1
Business Combination - Intangible Assets Acquired (Details) - USD ($)
3 Months Ended 12 Months Ended 15 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2025
Indefinite-Lived Intangible Assets [Roll Forward]      
Impairment $ 0 $ 0  
Goodwill      
Combination Date Fair Value 12,401,118    
Impairment 0    
Carrying Value 12,193,825 12,401,118 $ 12,401,118
Pharmagesic      
Indefinite-Lived Intangible Assets [Roll Forward]      
Combination Date Fair Value 68,985,026   69,500,000
Translation Adj (1,153,132)   (514,974)
Carrying Value 67,831,894 68,985,026 68,985,026
Goodwill      
Combination Date Fair Value 12,401,118   12,493,727
Translation Adj (207,293)   (92,609)
Carrying Value 12,193,825 12,401,118 12,401,118
Pharmagesic | Halneuron for Cancer Related Pain      
Indefinite-Lived Intangible Assets [Roll Forward]      
Combination Date Fair Value 59,456,159   59,900,000
Translation Adj (993,850)   (443,841)
Carrying Value 58,462,309 59,456,159 59,456,159
Pharmagesic | Halneuron for Chemotherapy Induced Neuropathic Pain      
Indefinite-Lived Intangible Assets [Roll Forward]      
Combination Date Fair Value 9,528,867   9,600,000
Translation Adj (159,282)   (71,133)
Carrying Value $ 9,369,585 $ 9,528,867 $ 9,528,867